Skip to main content
. Author manuscript; available in PMC: 2024 Feb 20.
Published in final edited form as: Liver Int. 2022 Oct 11;42(12):2607–2619. doi: 10.1111/liv.15432

Table 1.

Holistic approach to the patient with hepatocellular carcinoma

‐ Preventative measures to promote “liver health” at all levels: “to inform is to cure”
‐ Recognition of subjects with risk factors for liver disease and aggressive management
‐ Assessment and management of social determinants of health and removal of barriers to care
‐ Early treatment of liver disease to prevent chronicity
‐ Preservation of liver function in patient with cirrhosis and chemoprevention of progression
‐ Oncologic surveillance of patients at risk
‐ Diagnosis of liver cancer and treatment strategy
‐ Team-based multimodal treatment with personalization of care
‐ Establishment of a treatment strategy going beyond the single episode
‐ Management and treatment of comorbidities
‐ Evaluation of potential candidacy for liver transplant
‐ Post-treatment oncologic surveillance
‐ Retreatment of recurrence as needed and feasible, again through a team-based approach
‐ Identifying the transition time to palliative care and participation in palliative care delivery